Christoph U. Correll, MD - Improving the Management of Patients With Schizophrenia: What Is the Role of New and Emerging Treatment Options?
Improving the Management of Patients With Schizophrenia: What Is the Role of New and Emerging Treatment Options? (Source: PeerView CME/CE Video Podcast - Psychiatry)
Source: PeerView CME/CE Video Podcast - Psychiatry - December 15, 2014 Category: Psychiatry Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
CC Grand Rounds: (1) Childhood Onset Schizophrenia: Rare But Worth Studying (2) Child Pyschiatry: New Views from Neuroimaging
Presented by: (1) Judith Rapoport, MD, Chief, Child Psychiatry Branch, NIMH (2) Jay Giedd, MD, Chief, Section on Brain Imaging, Child Psychiatry Branch, NIMHCategory: Clinical Center Grand RoundsAired date: 01/15/2014 (Source: Videocast - All Events)
Source: Videocast - All Events - January 23, 2014 Category: Journals (General) Tags: Past Events Source Type: video
CC Grand Rounds: (1) Childhood Onset Schizophrenia: Rare But Worth Studying (2) Child Pyschiatry: New Views from Neuroimaging
CC Grand Rounds: (1) Childhood Onset Schizophrenia: Rare But Worth Studying (2) Child Psychiatry: New Views from NeuroimagingFor more information go to http://www.cc.nih.gov/about/news/grcurrent.htmlAir date: 1/15/2014 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - January 6, 2014 Category: Journals (General) Tags: Upcoming Events Source Type: video
Matching Complex Biomarkers to Drugs Using HistoReceptomic Signatures
NLM Informatics Lecture Series
Personalized medicine theorizes that individuals suffering from complex diseases exhibit unique genomic activity profiles to which drug treatments can be matched. Unfortunately, most drugs were discovered phenotypically and have unknown and complex mechanisms of action, making their matching to personalized profiles difficult. We derived a novel molecular signature for drug action by integrating a large set of drug:receptor affinities across the human proteome with receptor gene-expression data in human tissues. The resulting HistoReceptOmic signatures can potentially be used to match dia...
Source: Videocast - All Events - October 24, 2013 Category: Journals (General) Tags: Upcoming Events Source Type: video
Matching Complex Biomarkers to Drugs Using HistoReceptomic Signatures (NIH Only)
NLM Informatics Lecture Series
Personalized medicine theorizes that individuals suffering from complex diseases exhibit unique genomic activity profiles to which drug treatments can be matched. Unfortunately, most drugs were discovered phenotypically and have unknown and complex mechanisms of action, making their matching to personalized profiles difficult. We derived a novel molecular signature for drug action by integrating a large set of drug:receptor affinities across the human proteome with receptor gene-expression data in human tissues. The resulting HistoReceptOmic signatures can potentially be used to match dia...
Source: Videocast - All Events - October 24, 2013 Category: Journals (General) Tags: Upcoming Events Source Type: video
